Propagation of conformational changes during μ-opioid receptor activation

Nature. 2015 Aug 20;524(7565):375-8. doi: 10.1038/nature14680. Epub 2015 Aug 5.

Abstract

µ-Opioid receptors (µORs) are G-protein-coupled receptors that are activated by a structurally diverse spectrum of natural and synthetic agonists including endogenous endorphin peptides, morphine and methadone. The recent structures of the μOR in inactive and agonist-induced active states (Huang et al., ref. 2) provide snapshots of the receptor at the beginning and end of a signalling event, but little is known about the dynamic sequence of events that span these two states. Here we use solution-state NMR to examine the process of μOR activation using a purified receptor (mouse sequence) preparation in an amphiphile membrane-like environment. We obtain spectra of the μOR in the absence of ligand, and in the presence of the high-affinity agonist BU72 alone, or with BU72 and a G protein mimetic nanobody. Our results show that conformational changes in transmembrane segments 5 and 6 (TM5 and TM6), which are required for the full engagement of a G protein, are almost completely dependent on the presence of both the agonist and the G protein mimetic nanobody, revealing a weak allosteric coupling between the agonist-binding pocket and the G-protein-coupling interface (TM5 and TM6), similar to that observed for the β2-adrenergic receptor. Unexpectedly, in the presence of agonist alone, we find larger spectral changes involving intracellular loop 1 and helix 8 compared to changes in TM5 and TM6. These results suggest that one or both of these domains may play a role in the initial interaction with the G protein, and that TM5 and TM6 are only engaged later in the process of complex formation. The initial interactions between the G protein and intracellular loop 1 and/or helix 8 may be involved in G-protein coupling specificity, as has been suggested for other family A G-protein-coupled receptors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Animals
  • Binding Sites
  • Heterotrimeric GTP-Binding Proteins / metabolism
  • Lysine / metabolism
  • Mice
  • Models, Molecular
  • Morphinans / chemistry
  • Morphinans / metabolism
  • Morphinans / pharmacology
  • Nuclear Magnetic Resonance, Biomolecular
  • Protein Binding
  • Protein Conformation / drug effects
  • Pyrroles / chemistry
  • Pyrroles / metabolism
  • Pyrroles / pharmacology
  • Receptors, Adrenergic, beta-2 / chemistry
  • Receptors, Opioid, mu / chemistry*
  • Receptors, Opioid, mu / metabolism*
  • Single-Chain Antibodies / chemistry
  • Single-Chain Antibodies / metabolism
  • Single-Chain Antibodies / pharmacology
  • Structure-Activity Relationship
  • Substrate Specificity

Substances

  • BU72 compound
  • Morphinans
  • Pyrroles
  • Receptors, Adrenergic, beta-2
  • Receptors, Opioid, mu
  • Single-Chain Antibodies
  • Heterotrimeric GTP-Binding Proteins
  • Lysine